Hospital
Second Xiangya Hospital of Central South University中南大学湘雅二医院
At a glance
Published values only, each read from the record this page is built on. The listings behind them are in the section below.
-
Fudan University hospital rankings A++++ General list, 2023
-
National key clinical specialties 23 at evidence level A or B
-
Research platforms 2 national clinical research centres and state key laboratories
-
Published research 20 PubMed records we hold for this hospital (the newest twenty per hospital)
-
Registered studies 9 records we hold for this hospital, as registered
Rankings & accreditation
These listings are published by the bodies that run them, not by this site. Every line carries the year it was published and a link to its source; this is not a paid or promoted listing.
Fudan University hospital rankings
| Item | Rank / tier | Year | Caliber | Source |
|---|---|---|---|---|
| General list | A++++ | 2023 | Tier only; hospitals in the same tier are not ordered against each other | https://rank.cn-healthcare.com/fudan/national-general |
National key clinical specialties
Batch is not published by the source.
23 specialty rows, each carrying its own evidence level.
Each row carries its own evidence level and its own source. Level definitions are on the methodology page.
Values written in Chinese are quoted as published by the source.
National clinical research platforms
| Item | Rank / tier | Year | Caliber | Source |
|---|---|---|---|---|
| National Clinical Research Center for Metabolic Diseases 国家代谢性疾病临床医学研究中心 | National clinical research centre | 2013 | Platform hosted by this hospital | https://www.most.gov.cn/tztg/201306/t20130608_106459.html |
| National Clinical Research Center for Mental Disorders 国家精神心理疾病临床医学研究中心 | National clinical research centre | 2014 | Platform hosted by this hospital | https://www.most.gov.cn/xxgk/xinxifenlei/fdzdgknr/qtwj/qtwj2014/201410/W020141030592960626156.doc |
Conditions treated here
Conditions this site files under the specialties above. It is a record of the listings, not a recommendation.
For international patients
A line appears here only where we hold a record for it. A line that is missing has not been verified - ask us and we will put the question to the hospital.
Hospital details
- Chinese name
- 中南大学湘雅二医院
- English name
- Second Xiangya Hospital of Central South University
Values written in Chinese are quoted as published by the source.
The grade list reference is the date or review batch the official list was published under; it is quoted in the source's language.
Also known as
- The second xiangya hospital of central south university
Evidence for this condition
Selected using official public data sources
-
Colorectal cancer
National key clinical specialty
- General Surgery (level B) https://www.xyeyy.com/655/656/664/
Published research
- HO-1 Up-regulation and PINK1/Parkin-Mediated Mitophagy Contribute to the Anti-tumor Effects of Metochalcone in Colorectal Cancer. Research (Washington, D.C.), 2026
- Synthetically engineered probiotic suppresses colorectal cancer via inhibition of Wnt/β-catenin signaling. Cell reports. Medicine, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Urology nominated, Gastroenterology nominated in the Fudan list.
-
Breast cancer
Published research
- Ultrasound-Guided Axillary Management in Early-Stage Breast Cancer: From Diagnosis to De-Escalation. Cancers, 2026
- Disitamab vedotin for HER2-positive breast cancer with liver metastases: phase 3 results from the RC48-C006 phase 2/3 trial. Nature communications, 2026
2 more published studies
PubMed indexes 4 papers on this condition that name this hospital.
Also ranked: Urology nominated, Gastroenterology nominated in the Fudan list.
-
Lung cancer
National key clinical specialty
- Respiratory Medicine (level B) https://www.xyeyy.com/655/656/664/
- Thoracic Surgery (level B) https://www.xyeyy.com/655/656/664/
Published research
- DNA hypomethylation identifying clinical benefit subgroup of small-cell lung cancer: multi-omics analysis of a phase II trial with durvalumab plus olaparib as maintenance therapy. Journal for immunotherapy of cancer, 2026
- Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR-Variant Non-Small Cell Lung Cancer: The HARMONi-A Randomized Clinical Trial. JAMA, 2026
3 more published studies
PubMed indexes 5 papers on this condition that name this hospital.
Also ranked: Urology nominated, Gastroenterology nominated in the Fudan list.
-
Liver cancer
Published research
- FAP-α-Responsive Size-Transformable Lipid Nanoparticles for Stromal Remodeling and Enhanced Drug Penetration in Fibrotic Hepatocellular Carcinoma. ACS applied materials & interfaces, 2026
- Psychological Stress Associated Bile Acid Reprogramming Promotes Hepatocellular Carcinoma Progression. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Urology nominated, Gastroenterology nominated in the Fudan list.
-
Stomach cancer
Published research
- Cost-effectiveness of targeted therapy versus chemotherapy for patients with advanced or metastatic gastric cancer in China. Frontiers in pharmacology, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Urology nominated, Gastroenterology nominated in the Fudan list.
-
Prostate cancer
Fudan specialty reputation ranking 2023
- Urology nominated https://www.fdygs.com/news2023-1.aspx
Published research
- CXCR2-mediated metabolic interaction between prostate cancer cells and the immunosuppressive tumor microenvironment. Journal for immunotherapy of cancer, 2026
- GLUL drives metabolic reprogramming and confers docetaxel resistance in prostate cancer. Biochemical pharmacology, 2026
1 more published study
PubMed indexes 3 papers on this condition that name this hospital.
Also ranked: Gastroenterology nominated in the Fudan list.
-
Thyroid cancer
Published research
- HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression. Cancer immunology, immunotherapy : CII, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Urology nominated, Gastroenterology nominated in the Fudan list.
-
Nasopharyngeal carcinoma
National key clinical specialty
- Otorhinolaryngology (level B) https://www.xyeyy.com/655/656/664/
Published research
- Becotatug Vedotin Combined With Pucotenlimab in Platinum- and Immunotherapy-Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Urology nominated, Gastroenterology nominated in the Fudan list.
-
Esophageal cancer
National key clinical specialty
- Thoracic Surgery (level B) https://www.xyeyy.com/655/656/664/
Published research
- The association between coffee consumption and esophageal cancer risk: a systematic review and meta-analysis of current observational evidence. Journal of gastrointestinal oncology, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Urology nominated, Gastroenterology nominated in the Fudan list.
-
Bladder cancer
Fudan specialty reputation ranking 2023
- Urology nominated https://www.fdygs.com/news2023-1.aspx
Also ranked: Gastroenterology nominated in the Fudan list.
-
Pancreatic cancer
National key clinical specialty
- General Surgery (level B) https://www.xyeyy.com/655/656/664/
Also ranked: Urology nominated, Gastroenterology nominated in the Fudan list.
-
Kidney cancer
Fudan specialty reputation ranking 2023
- Urology nominated https://www.fdygs.com/news2023-1.aspx
Also ranked: Gastroenterology nominated in the Fudan list.
-
Senile cataract
National key clinical specialty
- Ophthalmology (level B) https://www.xyeyy.com/655/656/664/
Also ranked: Urology nominated, Gastroenterology nominated in the Fudan list.
-
Non-Hodgkin lymphoma
National key clinical specialty
- Hematology (level B) https://www.xyeyy.com/655/656/664/
Also ranked: Urology nominated, Gastroenterology nominated in the Fudan list.
-
Leukaemia
National key clinical specialty
- Hematology (level B) https://www.xyeyy.com/655/656/664/
Also ranked: Urology nominated, Gastroenterology nominated in the Fudan list.
-
Hip and knee replacement
National key clinical specialty
- Orthopedics (level B) https://www.xyeyy.com/655/656/664/
Also ranked: Urology nominated, Gastroenterology nominated in the Fudan list.
-
Coronary artery bypass and valve surgery
National key clinical specialty
- Cardiac Surgery (level B) https://www.xyeyy.com/655/656/664/
Also ranked: Urology nominated, Gastroenterology nominated in the Fudan list.
-
Congenital heart disease
National key clinical specialty
- Cardiac Surgery (level B) https://www.xyeyy.com/655/656/664/
Also ranked: Urology nominated, Gastroenterology nominated in the Fudan list.
-
Bone and soft tissue sarcoma
National key clinical specialty
- Orthopedics (level B) https://www.xyeyy.com/655/656/664/
Also ranked: Urology nominated, Gastroenterology nominated in the Fudan list.
Other hospitals in Changsha
Source & evidence
- Source URL
- https://rank.cn-healthcare.com/fudan/national-general
- Source scheme
- https
- Source type
- Third-party compilation
- Evidence level
- B - hospital self-statement or authoritative media
- Retrieved on
- 2026-09-24